
    
      This study will investigate the efficacy of G-CSF mobilized mononuclear cell injection of
      patients with PAD who presented with intermittent claudication. Forty PAD patients who
      presented with intermittent claudication will be randomized into 2 groups. The control group
      will be treated by medication and walking exercise 3 times/ week. The experiment group will
      be injected G-CSF mobilized mononuclear cell ,medication and walking exercise 3 times/ week.
      Ankle brachial index(ABI), Toe brachial index (TBI) and transcutaneous oxygen measurement
      will be evaluated at the day of randomization, 1 , 3, 6 and 12 months in the control group
      and day of randomization, 1 , 3, 6 and 12 months after injection of PB-MNC in the experiment
      group. Pain free walking distance will be evaluated at the day of randomization, 1 , 3, 6 and
      12 months by pedometer.
    
  